EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiation

Jaimy Joy, Ana Gervassi, Lennie Chen, Brent Kirshenbaum, Sheila Styrchak, Daisy Ko, Sherry McLaughlin, Danica Shao, Ewelina Kosmider, Paul T Edlefsen, Janine Maenza, Ann C Collier und 3 weitere

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci159569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Jaimy Joy und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA. Hauptthemen laut MEDLINE: HIV Infections, Proviruses, CD4-Positive T-Lymphocytes, Virus Integration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health/UW, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsProvirusesCD4-Positive T-LymphocytesVirus IntegrationHIV-1HumansMaleFemaleAdultEnhancer of Zeste Homolog 2 ProteinDNA, ViralAnti-Retroviral Agents

Stichwörter der Autor:innen

AIDS/HIVAntigenCytokinesT cellsVirology

Substanzen

Enhancer of Zeste Homolog 2 ProteinEZH2 protein, humanDNA, ViralAnti-Retroviral Agents

Autor:innen und Institutionen

  • Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.
  • Department of Microbiology, University of Washington, Seattle, Washington, USA.
  • Center for Infectious Disease Research, Seattle, Washington, USA.
  • Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Department of Medicine.
  • Department of Global Health.

Förderung

  • NIAID NIH HHS
  • National Institutes of Health/UW
  • National Institutes of Health
  • National Institutes of Health/UCLA

Zitieren

APA

Joy, J., Gervassi, A., Chen, L., Kirshenbaum, B., Styrchak, S., Ko, D., McLaughlin, S., Shao, D., Kosmider, E., Edlefsen, P. T., Maenza, J., Collier, A. C., Mullins, J. I., Horton, H., & Frenkel, L. M. (2024). Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiation. Journal of Clinical Investigation. https://doi.org/10.1172/jci159569

Vancouver

Joy J, Gervassi A, Chen L, Kirshenbaum B, Styrchak S, Ko D, et al. Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiation. Journal of Clinical Investigation. 2024. doi:10.1172/jci159569

BibTeX
@article{Joy2024,
  author = {Joy, Jaimy and Gervassi, Ana and Chen, Lennie and Kirshenbaum, Brent and Styrchak, Sheila and Ko, Daisy and McLaughlin, Sherry and Shao, Danica and Kosmider, Ewelina and Edlefsen, Paul T and Maenza, Janine and Collier, Ann C and Mullins, James I and Horton, Helen and Frenkel, Lisa M},
  title = {Antigen specificities and proviral integration sites differ in HIV-infected cells by timing of antiretroviral treatment initiation},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci159569}
}
Kostenlos starten →